about
Omega 3 fatty acids for the treatment of dementia and cognitive impairmentThe VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular diseaseIcosapent ethyl for the treatment of severe hypertriglyceridemia.Functional and pathological roles of the 12- and 15-lipoxygenasesFish consumption, marine omega-3 fatty acids, and incidence of heart failure: a population-based prospective study of middle-aged and elderly menEffects of specific multi-nutrient enriched diets on cerebral metabolism, cognition and neuropathology in AβPPswe-PS1dE9 miceSecondary prevention of heart disease--knowledge among cardiologists and omega-3 (omega-3) fatty acid prescribing behaviors in Karachi, Pakistan.New data on the clinical impact of exercise training, fish oils, and statins in heart failure.Omega-3 fatty acids and dementia.Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease.Polyunsaturated fatty acids and cardiovascular disease: implications for nutrigeneticsModulating human aging and age-associated diseases.To B or not to B: is non-high-density lipoprotein cholesterol an adequate surrogate for apolipoprotein B?Comparative effectiveness of fish oil versus fenofibrate, gemfibrozil, and atorvastatin on lowering triglyceride levels among HIV-infected patients in routine clinical care.Nutritional assessment in heart failure patients.Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial.Bioavailability and potential uses of vegetarian sources of omega-3 fatty acids: a review of the literature.Uses and benefits of omega-3 ethyl esters in patients with cardiovascular disease.Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease: a contemporary meta-analysis of randomized, controlled trials.Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial.Dietary intake of nuts and cardiovascular prognosisThe russert impact: a golden opportunity to promote primary coronary prevention.Fish oil in primary and secondary cardiovascular preventionMarine bioactives as functional food ingredients: potential to reduce the incidence of chronic diseasesDietary n-3 polyunsaturated fatty acid intakes modify the effect of genetic variation in fatty acid desaturase 1 on coronary artery disease.Omega-3 fatty acid deficiency increases stearoyl-CoA desaturase expression and activity indices in rat liver: positive association with non-fasting plasma triglyceride levels.Nutraceutical therapies for atherosclerosis.EPA Prevents the Development of Abdominal Aortic Aneurysms through Gpr-120/Ffar-4.Effect of consuming novel foods consisting high oleic canola oil, barley β-glucan, and DHA on cardiovascular disease risk in humans: the CONFIDENCE (Canola Oil and Fibre with DHA Enhanced) study - protocol for a randomized controlled trial.Consequences of essential fatty acids.A Dietary Treatment Improves Cerebral Blood Flow and Brain Connectivity in Aging apoE4 MiceA fish a day, keeps the cardiologist away! - A review of the effect of omega-3 fatty acids in the cardiovascular system.The effect of n-3 polyunsaturated fatty acids on incidence and severity of oxaliplatin induced peripheral neuropathy: a randomized controlled trialThe concomitant consumption of cod liver oil causes a reduction in the daily diclofenac sodium usage in rheumatoid arthritis patients: a pilot study.Expanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care.Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study.Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approachEstablished and emerging approaches for the management of dyslipidaemia.Enteral nutrition in the cardiothoracic intensive care unit: challenges and considerations.Modifying influence of dietary sugar in the relationship between cortisol and visceral adipose tissue in minority youth.
P2860
Q24234477-B92A1746-463F-4CF4-B8AD-08CB38044C66Q24613094-A92BF23B-F445-41B5-9769-EB9F009396D3Q27686834-1CE8BF43-C50E-4605-847E-7FCFE01F2024Q28296453-A97B18E1-267A-4388-966B-9A151F799C61Q28389253-0FCC521D-CF0D-4611-A6D4-86120E1C3CB4Q28533783-6E42D31B-4EA3-4A8B-819A-A2BCC8BD741CQ33403376-DE886044-2697-4175-AEC1-18DE5D3AB27CQ33521834-033EB95E-55BA-4D8B-96E1-3EEBBE5FD8DBQ33602402-4E6E2DC4-050F-4D98-AFBE-D994B2F66098Q33641823-177F2703-C05A-4B69-A9F9-57B5A8BC2548Q33647546-0DB04AFD-99F7-45E3-98F2-0684A68DFA91Q33693445-3A9EF07C-C82D-41F9-B827-FA38E7EE4361Q33820018-99DE0BFF-7FCF-4398-A227-8EAA79557CF1Q33956562-3A4F9CC3-F7F1-4501-BE2E-601DED4127B6Q34203668-108BFCE3-17B0-4E06-AD57-10B815A9C34DQ34380579-AEC2DBE5-244B-493F-AB24-3544C2A53776Q34386753-1900D2DA-316C-48B1-83DA-5423BA8070A4Q34418028-45FA0812-9800-4217-9D95-BDFB9AB39814Q34629651-8C004077-00B6-4223-AB3B-2F501FE285FEQ34736255-E679CC40-66ED-4DF5-AE63-DC072D374523Q34986292-D7AB9EF7-BF50-4233-A1BD-22449046CDC9Q34986590-D94999BA-398F-49FA-A1A3-3ECFF87FA3C7Q34986662-18FE6FBF-FC02-45C3-A809-DB84BDBB9D8CQ35091730-FB000E1F-071D-424F-B2D5-C88E226F8334Q35300503-97521E64-8667-4266-81E1-73EB887F44C1Q35633941-5CBFCAB6-4405-4B70-8511-280B31DC37B4Q36068816-D40D93DF-A453-48F8-97AF-0F2C8AA1DA65Q36169495-395546B2-CF4E-453E-844A-C52C6FB26B84Q36234827-EFFA4FE4-5764-42F8-9198-C9A77C8E08D8Q36329733-E664D99A-DF38-49D6-8E02-52F525E68EF8Q36724664-45201E8B-91F0-40EC-90A7-5B28429A49A0Q37015975-4657BB4F-0E07-46CA-8249-63E50FE17C87Q37031281-9C3154DA-8528-4254-BCB3-09782D56D82FQ37111312-E99BE1ED-960A-4086-BCF7-690EC198AE6DQ37148386-45C4BABD-2135-4CC7-A515-75F0861F1355Q37279061-A636F855-4F81-4196-A0A8-26F81C8DE2D8Q37285574-9AB708A0-4305-4829-A794-A87363ED69EFQ37288105-885414F3-843A-4B5E-B6D5-1EF68331D910Q37292161-043CBC4F-E6FD-4095-81C3-1039054AD239Q37624457-E8D19DA3-3971-49AE-820C-4E1D985416A8
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Omega-3 fatty acids for cardioprotection.
@ast
Omega-3 fatty acids for cardioprotection.
@en
Omega-3 fatty acids for cardioprotection.
@nl
type
label
Omega-3 fatty acids for cardioprotection.
@ast
Omega-3 fatty acids for cardioprotection.
@en
Omega-3 fatty acids for cardioprotection.
@nl
prefLabel
Omega-3 fatty acids for cardioprotection.
@ast
Omega-3 fatty acids for cardioprotection.
@en
Omega-3 fatty acids for cardioprotection.
@nl
P2093
P356
P1476
Omega-3 fatty acids for cardioprotection
@en
P2093
Carl J Lavie
John H Lee
Roberto Marchioli
William S Harris
P304
P356
10.4065/83.3.324
P407
P577
2008-03-01T00:00:00Z